Dana Investment Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Dana Investment Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $2.19 Million - $2.69 Million	-4,898 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $1.57 Million - $2 Million	-3,287 Reduced 40.16%	4,898 $2.37 Million
Q3 2020 Nov 10, 2020	SELL	$544.75 - $658.21 $4.33 Million - $5.23 Million	-7,943 Reduced 49.25%	8,185 $4.58 Million
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $7.1 Million - $9.26 Million	-14,387 Reduced 47.15%	16,128 $10.1 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $10 Million - $14.8 Million	29,847 Added 4468.11%	30,515 $14.9 Million
Q4 2019 Feb 11, 2020	BUY	$274.13 - $376.51 $183,118 - $251,508	668 New	668 $251,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.